Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 34, Status: Authorised
الصحة واللياقة البدنية
Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 34, Status: Authorised
Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 34, Status: Authorised
AAdmin
١٧ أغسطس ٢٠٢٦
1 دقيقة قراءة
